Center-Authored Papers

Filters: Author is Fitzgibbon, Matthew  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
McIntosh MW, Fitzgibbon M.  2009.  Biomarker validation by targeted mass spectrometry.. Nature biotechnology. 27(7):622-3.
Morrish F, Noonan J, Perez-Olsen CL, Gafken PR, Fitzgibbon M, Kelleher J, Van Gilst M, Hockenbery DM.  2010.  Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry.. The Journal of biological chemistry. 285(47):36267-74. Abstract
P
Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda EA, Wang H, Zhang Q, Newcomb L, Krasnoselsky A, Paczesny S, Choi G et al..  2008.  Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.. Journal of proteome research. 7(4):1481-9. Abstract
V
Veatch JR, Lee SM, Fitzgibbon M, Chow I-T, Jesernig B, Schmitt T, Kong YY, Kargl J, Houghton MGA, Thompson JA et al..  2018.  Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma.. The Journal of clinical investigation. 128(4):1563-1568. Abstract
Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton MGA, Riddell SR.  2019.  Endogenous CD4 T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic and () Driver Mutations.. Cancer immunology research. 7(6):910-922. Abstract
Z
Zhao W, Fitzgibbon M, Bergan L, Clegg N, Crispin D, Mills GB, McIntosh M.  2017.  Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.. Cancer journal (Sudbury, Mass.). 23(2):108-114. Abstract